Tonya Orchard

Tonya Orchard

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2016 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
TOTonya Orchard
Tonya Orchard
VYVedat Yildiz
Vedat Yildiz
SSSusan E Steck
Susan E Steck
JHJames R Hébert
James R Hébert
YMYunsheng Ma
Yunsheng Ma
RJRebecca D Jackson
Rebecca D Jackson
Previous studies suggest that bone loss and fracture risk are associated with higher inflammatory milieu, potentially modifiable by diet. The primary objective of this analysis was to evaluate the association of the dietary inflammatory index (DII), a measure of the inflammatory potential of diet, with risk of hip, lower‐arm, and total fracture using longitudinal data from the Women's Health Initiative Observational Study and Clinical Trials. Secondarily, we evaluated changes in bone mineral density (BMD) and DII scores. DII scores were calculated from baseline food frequency questionnaires (FFQs) completed by 160,191 participants (mean age 63 years) without history of hip fracture at enrollment. Year 3 FFQs were used to calculate a DII change score. Fractures were reported at least annually; hip fractures were confirmed by medical records. Hazard ratios for fractures were computed using multivariable‐adjusted Cox proportional hazard models, further stratified by age and race/ethnicity. Pairwise comparisons of changes in hip BMD, measured by dual‐energy X‐ray absorptiometry from baseline, year 3, and year 6 were analyzed by quartile (Q1 = least inflammatory diet) of baseline DII scores in a subgroup of women (n = 10,290). Mean DII score improved significantly over 3 years (p < 0.01), but change was not associated with fracture risk. Baseline DII score was only associated with hip fracture risk in younger white women (HR Q4,1.48; 95% CI, 1.09 to 2.01; p = 0.01). There were no significant associations among white women older than 63 years or other races/ethnicities. Women with the least inflammatory DII scores had less loss of hip BMD (p = 0.01) by year 6, despite lower baseline hip BMD, versus women with the most inflammatory DII scores. In conclusion, a less inflammatory dietary pattern was associated with less BMD loss in postmenopausal women. A more inflammatory diet was associated with increased hip fracture risk only in white women younger than 63 years. © 2016 American Society for Bone and Mineral Research.

13 May 2024 in Cancer
Verified
Journal Article
Closed access
RCRowan T Chlebowski
Rowan T Chlebowski
AAAaron K Aragaki
Aaron K Aragaki
KPKathy Pan
Kathy Pan
Michael S. SimonMichael S. Simon
Michael S. Simon
MNMarian L Neuhouser
Marian L Neuhouser
JMJoAnn E Manson
JoAnn E Manson

1 December 2021 in Environmental Health Perspectives
Verified
Journal Article
Closed access
CCCheng Chen
Cheng Chen
Kathleen HaydenKathleen Hayden
Kathleen Hayden
JKJoel Kaufman
Joel Kaufman
MEMark A. Espeland
Mark A. Espeland
EWEric A. Whitsel
Eric A. Whitsel
KKKa KaHe
Ka KaHe

1 April 2018 in Journal of the Academy of Nutrition and Dietetics
Verified
Journal Article
Closed access
TOTonya Orchard
Tonya Orchard
RARebecca R. Andridge
Rebecca R. Andridge
LYLisa D. Yee
Lisa D. Yee
MLMaryam B. Lustberg
Maryam B. Lustberg

8 December 2016 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
TOTonya Orchard
Tonya Orchard
MGMonica M. Gaudier-Diaz
Monica M. Gaudier-Diaz
KWKellie Weinhold
Kellie Weinhold
ADA. Courtney DeVries
A. Courtney DeVries

18 December 2018 in Nutrients
Verified
Journal Article
Open access
TOTonya Orchard
Tonya Orchard
MGMonica M. Gaudier-Diaz
Monica M. Gaudier-Diaz
PPPanchita Phuwamongkolwiwat-Chu
Panchita Phuwamongkolwiwat-Chu
RARebecca Andridge
Rebecca Andridge
MLMaryam Lustberg
Maryam Lustberg
ADA. Courtney DeVries
A. Courtney DeVries
Chemotherapeutic agents such as doxorubicin may negatively affect long-term brain functioning in cancer survivors; neuroinflammation may play a causal role. Dietary approaches that reduce inflammation, such as lowering sucrose and increasing eicosapentaenoic acid plus docosahexaenoic acid (EPA + DHA), may attenuate chemotherapy-induced neuroinflammation and synaptic damage, thereby improving quality of life. Ovariectomized, C57BL/6 mice were assigned to a chemotherapy (9 mg/kg doxorubicin + 90 mg/kg cyclophosphamide) or vehicle two-injection regimen, with injections two and four weeks after starting diets. In Study 1, mice received low sucrose diets with EPA + DHA or No EPA + DHA for four to six weeks; tissues were collected four, seven, or 14 days after the second injection. Compared to vehicle, chemotherapy increased pro-inflammatory cytokine IL-1β at day seven in the cortex and hippocampus, and reduced gene expression of synaptic marker Shank 3 at all timepoints in cortex, while EPA + DHA increased expression of Shank 3. In Study 2, high or low sucrose/EPA + DHA or No EPA + DHA diets were fed for five weeks; tissues were collected ten days after the second injection. Among chemotherapy-treated mice, brain DHA was higher with low sucrose feeding. Furthermore, low sucrose increased gene expression of Shank 1, while EPA + DHA increased expression of Shank 3 and reduced protein concentrations of pro-inflammatory markers IL-5, IL-6 and KC/GRO in the cortex, but not the hippocampus. Low sucrose, EPA + DHA diets may attenuate neuroinflammation and synaptic damage induced by doxorubicin-based chemotherapy in specific brain regions.